The Hypertension and Heart Failure Drugs Market is anticipated to gain exponential industry growth over the given forecast period of 2022-2028. Hypertension and Heart Failure Drugs such as ß-blockers, angiotensin-converting enzyme inhibitiors, angiotensin receptor blockers, aldosterone receptor blockers, hydralazine and nitrates, which have shown mortality benefit in CHF and exert antihypertensive effects, are used as […]
